Level A· Stronger Clinical EvidenceMeta-analysisPubMed

Superior Retention of Aged Fat Graft by Supplementing Young Adipose-Derived Stromal Cells in a Murine Model.

Tran VVT., Jin X., Zhou XY., Hong KY., Chang H.

Meta-analysis with a reported sample of 6 on Facial Rejuvenation, published in Plast Reconstr Surg (2024) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Meta-analysis
Journal
Plast Reconstr Surg (2024)
Country
United States
Reported sample size
6
Source database
PubMed
PMID
39451136
DOI
10.1097/PRS.0000000000011810
Citations
1

Abstract (original English)

In 2021, a meta-analysis showed that fat graft retention varied from 26% to 83%. In a retrospective study including patients with Parry-Romberg syndrome, the younger age group had higher satisfaction scores (3.8 versus 3.0) after fat grafting. Cell-assisted lipotransfer could be an alternative to overcome the instability of volume loss; however, no study has investigated its effect on older recipients. In an in vitro study, adipose-derived stromal cells (ASCs) from aged and young (52 and 8 weeks old) DsRed B6 mice were characterized by proliferation rates as percentages of Ki-67-positive cells. In addition, 68-week-old wild-type B6 mice received 150 µL of green fluorescent protein fat (from 69-week-old B6 mice) mixed with saline or 3 × 10 5 aged or young DsRed ASCs (N, A, and Y groups, respectively) on the scalp ( n = 6/group). After 8 weeks, graft volumes were evaluated using microcomputed tomography. Vessel densities were tracked by percentages of CD31 using immunofluorescence staining. Young ASCs showed higher proliferation than aged ASCs (47.1% and 26.2%, respectively; P < 0.05). The Y group showed the highest graft retention (median: N, 41.0%; A, 52.2%; Y, 65.2%; P < 0.05) and percentage of blood vessels (median: N, 27.7%; A, 43.5%; Y, 54.7%; P < 0.05) among the 3 groups. Cell-assisted lipotransfer is effective with older recipients. Higher effect was observed by supplemen

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence
AnimalsMiceGraft SurvivalAdipose TissueAge FactorsScalpCell ProliferationMaleStromal CellsMice, Inbred C57BL

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research